Introduction: 

Early and effective treatment is fundamental in status epilepticus (SE) management. At the initiative of the Epilepsy Council of Malaysia, this study aimed to determine the treatment gap in SE across different healthcare settings in Malaysia.

Methods: 

A web-based survey was sent to clinicians involved in the management of SE, across all states and at all levels of healthcare services.

Results: 

A total of 158 responses were received from 104 health facilities, including 23 tertiary government hospitals (95.8% of all government tertiary hospitals in Malaysia), 4 (80.0%) universities, 14 (6.7%) private, 15 (11.5%) district hospitals and 21 clinics. Intravenous (IV) diazepam was available in 14 (93.3%) district and 33 (80.5%) tertiary hospitals for prehospital management. Non-IV benzodiazepine (rectal diazepam and intramuscular midazolam) was not widely available in prehospital services (75.8% and 51.5%). Intramuscular midazolam was underutilised (60.0% in district and 65.9% in tertiary hospitals). IV sodium valproate and levetiracetam were only available in 66.7% and 53.3% of the district hospitals, respectively. Electroencephalogram (EEG) services were available in only 26.7% of the district hospitals. Non-pharmacological therapies such as ketogenic diet, electroconvulsive therapy, and therapeutic hypothermia were not available in most district and tertiary hospitals for refractory and super-refractory SE.

Conclusions: 

We identified several gaps in the current practice of SE management, including limited availability and underutilization of non-IV midazolam in prehospital services, underutilization of non-IV midazolam and other second-line ASMs, and lack of EEG monitoring in district hospitals and limited treatment options for refractory and super-refractory SE in tertiary hospitals.

1. Berg, A.T. ∙ Shinnar, S. ∙ Levy, S.R. ...Status epilepticus in children with newly diagnosed epilepsy. Ann Neurol. 1999; 45:618-623
2. Berg, A.T. ∙ Shinnar, S. ∙ Testa, F.M. ...Status epilepticus after the initial diagnosis of epilepsy in children. Neurology. 2004; 63(6):1027-1034
3. DeLorenzo, R.J. ∙ Pellock, J.M. ∙ Towne, A.R. ...Epidemiology of status epilepticus. J Clin Neurophysiol. 1995; 12(4):316-325
4. Cascino, G.D. Generalized convulsive status epilepticus. Mayo Clin Proc. 1996; 71:787-792
5. Ong, C.-T. ∙ Sheu, S.-M. ∙ Tsai, C.-F. ... Age-dependent sex difference of the incidence and mortality of status epilepticus: a twelve year nationwide population-based cohort study in Taiwan. PLoS One. 2015; 10(3), e0122350
6. Tiamkao, S. ∙ Pranbul, S. ∙ Sawanyawisuth, K. ...A national database of incidence and treatment outcomes of status epilepticus in Thailand. Int J Neurosci. 2014; 124(6):416-420
7. Betjemann, J.P. ∙ Lowenstein, D.H. Status epilepticus in adults. Lancet Neurol. 2015; 14:615-624
8. Kantanen, A.-M. ∙ Reinikainen, M. ∙ Parviainen, I. ...Incidence and mortality of super-refractory status epilepticus in adults. Epilepsy Behav. 2015; 49:131-134
9. Crawshaw, A.A. ∙ Cock, H.R. Medical management of status epilepticus: emergency room to intensive care unit. Seizure. 2020; 75:145-152
10. Trinka, E. ∙ Kälviäinen, R. 25 years of advances in the definition, classification and treatment of status epilepticus. Seizure. 2017; 44:65-73
11. Consensus guidelines on the management of epilepsy 2017. https://www.neuro.org.my/assets/guideline/2017Epilepsy.pdf. 2017. [May 18].
12. Lee, B.Treatment gap for convulsive status epilepticus in resource-poor countries. Epilepsia. 2018; 59(Suppl 2):135-139
13. Glauser, T. ∙ Shinnar, S. ∙ Gloss, D. ...Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the American Epilepsy Society. Epilepsy Curr. 2016; 16(1):48-61
14. Trinka, E. ∙ Cock, H. ∙ Hesdorffer, D. ...A definition and classification of status epilepticus—Report of the ILAE Task Force on classification of status epilepticus. Epilepsia. 2015; 56(10):1515-1523
15. Shorvon, S. ∙ Ferlisi, M. The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. Brain. 2011; 134:2802-2818
16. List of government hospitals. https://www.moh.gov.my/index.php/database_stores/store_view/82. 2022. [April 4].
17. Health facts 2019. https://www.moh.gov.my/moh/resources/Penerbitan/Penerbitan%20Utama/HEALTH%20FACTS/Health%20Facts%202019_Booklet.pdf. 2019. [April 4].
18. Hospital Management Unit, Medical Development Division, Ministry of Health Malaysia.Strategic framework of the medical programme 2021-2025. https://www.moh.gov.my/moh/resources/Pelan_Strategik_KKM.pdf. 2020. [May 1].
19. Neligan, A. ∙ Noyce, A.J. ∙ Gosavi, T.D. ... Change in mortality of generalized convulsive status epilepticus in high-income countries over time: a systematic review and meta-analysis. JAMA Neurol. 2019; 76:897-905
20. Khor, S.B. ∙ Lim, K.S. ∙ Fong, S.L. ... Mortality in adult epilepsy patients in Malaysia: a hospital-based study. Seizure. 2021; 88:56-59
21. Alldredge, B.K. ∙ Gelb, A.M. ∙ Isaacs, S.M. ... A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med. 2001; 345(9):631-637
22. Silbergleit, R. ∙ Lowenstein, D. ∙ Durkalski, V. ... RAMPART (Rapid Anticonvulsant Medication Prior to Arrival Trial): a double-blind randomized clinical trial of the efficacy of intramuscular midazolam versus intravenous lorazepam in the prehospital treatment of status epilepticus by paramedics. Epilepsia. 2011; 52(Suppl 8):45-47
23. McMullan, J. ∙ Sasson, C. ∙ Pancioli, A. ... Midazolam versus diazepam for the treatment of status epilepticus in children and young adults: a meta-analysis. Acad Emerg Med. 2010; 17:575-582
24. Silbergleit, R. ∙ Durkalski, V. ∙ Lowenstein, D. ... Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med. 2012; 366(7):591-600
25. Kapur, J. ∙ Elm, J. ∙ Chamberlain, J.M. ... Randomized trial of three anticonvulsant medications for status epilepticus. N Engl J Med. 2019; 381(22):2103-2113
26. Leppik, I.E. Status epilepticus in the elderly. Epilepsia. 2018; 59:140-143
27. Li, W. ∙ Schneider, A.L. ∙ Scheffer, I.E. Defining Dravet syndrome: an essential pre-requisite for precision medicine trials. Epilepsia. 2021; 62:2205-2217
28. Cross, J.H. ∙ Caraballo, R.H. ∙ Nabbout, R. ... Dravet syndrome: treatment options and management of prolonged seizures. Epilepsia. 2019; 60(Suppl 3):S39-S48
29. Lim, K.S. ∙ Kwan, P. ∙ Tan, C.T. Association of HLA-B* 1502 allele and carbamazepine-induced severe adverse cutaneous drug reaction among Asians, a review. Neurol Asia. 2008; 13:15-21
30. Williams, T.J. ∙ Cervenka, M.C. The role for ketogenic diets in epilepsy and status epilepticus in adults. Clin Neurophysiol Pract. 2017; 2:154-160
31. Ahmed, J. ∙ Metrick, M. ∙ Gilbert, A. ... Electroconvulsive therapy for super refractory status epilepticus. J Ect. 2018; 34(1):e5-e9
32. Tan, H.J. ∙ Tee, T.Y. ∙ Husin, M. ... A case series of super-refractory status epilepticus successfully treated with electroconvulsive therapy. Epileptic Disord. 2020; 22:828-833
33. García-López, B. ∙ Gómez-Menéndez, A.I. ∙ Vázquez-Sánchez, F. ... Electroconvulsive therapy in super refractory status epilepticus: case series with a defined protocol. Int J Environ Res Public Health. 2020; 17(11):4023
34. Byun, J.-I. ∙ Lee, S.-T. ∙ Jung, K.-H. ... Effect of immunotherapy on seizure outcome in patients with autoimmune encephalitis: a prospective observational registry study. PLoS One. 2016; 11(1), e0146455
35. Toledano, M. ∙ Britton, J.W. ∙ McKeon, A. ... Utility of an immunotherapy trial in evaluating patients with presumed autoimmune epilepsy. Neurology. 2014; 82(18):1578-1586
36. Persatuan Epilepsi Malaysia. Resources for teachers and parents. https://sites.google.com/site/malaysiansocietyofepilepsy/patient-information/resources-for-teachers-parents?authuser=0#h.6pe1n7arwcmb. 2021. [9th December 2022].
37. Menon, V. ∙ Muraleedharan, A. Internet-based surveys: relevance, methodological considerations and troubleshooting strategies. G E NPsychiatr. 2020; 33(5), e100264
38. Guidelines on Neonatal Seizures: World Health Organization; 2011.